NEW YORK (360Dx) – Beckman Coulter Diagnostics said today that it has received US Food and Drug Administration clearance for its automated Access AMH test, a paramagnetic particle chemiluminescent immunoassay for the quantitative determination of anti-Müllerian hormone levels.

Beckman noted that the anti-Müllerian hormone test aids healthcare providers in the assessment of a woman’s ovarian reserve and helps guide the clinical management of women struggling with infertility or planning to become pregnant later in life.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.